BioLineRx Ltd. Enters Into Share Purchase Agreement With Lincoln Park Capital
5/30/2014 9:36:01 AM
JERUSALEM--(BUSINESS WIRE)--BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has signed a purchase agreement for the sale, from time to time, of up to $20 million of its American Depositary Shares (“ADSs”) with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor.
Help employers find you! Check out all the jobs and post your resume.
comments powered by